LASTACAFT is a Ophthalmic Solution/ Drops in the Human Otc Drug category. It is labeled and distributed by Allergan, Inc.. The primary component is Alcaftadine.
| Product ID | 0023-4291_3110f1f0-8f7d-425b-8ed5-99673f085be6 |
| NDC | 0023-4291 |
| Product Type | Human Otc Drug |
| Proprietary Name | LASTACAFT |
| Generic Name | Alcaftadine |
| Dosage Form | Solution/ Drops |
| Route of Administration | OPHTHALMIC |
| Marketing Start Date | 2021-12-01 |
| Marketing Category | NDA / |
| Application Number | NDA022134 |
| Labeler Name | Allergan, Inc. |
| Substance Name | ALCAFTADINE |
| Active Ingredient Strength | 3 mg/mL |
| Pharm Classes | Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2021-12-01 |
| NDC Exclude Flag | N |
| Sample Package? | Y |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0023-4290 | LASTACAFT | alcaftadine |
| 0023-4291 | LASTACAFT | alcaftadine |
| 42254-288 | LASTACAFT | alcaftadine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() LASTACAFT 85168259 4071760 Live/Registered |
Allergan, Inc. 2010-11-03 |
![]() LASTACAFT 85088422 4003795 Live/Registered |
Allergan, Inc. 2010-07-20 |